Cargando…

Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England

Detalles Bibliográficos
Autores principales:	Bromilow, Tom, Holmes, Hayden, Coote, Laura, Woods, Sam, Pink, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471521/ https://www.ncbi.nlm.nih.gov/pubmed/37535235 http://dx.doi.org/10.1007/s41669-023-00434-x

Ejemplares similares

Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England
por: Bromilow, Tom, et al.
Publicado: (2023)

Correction to: An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily
por: Medaglia, Alice Annalisa, et al.
Publicado: (2021)

Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
por: Jiang, Yiling, et al.
Publicado: (2022)

Costs Associated with the Treatment of Clostridioides Difficile Infections
por: Sierocka, Aleksandra, et al.
Publicado: (2021)

Author Correction: Genetic variation in the human leukocyte antigen region confers susceptibility to Clostridioides difficile infection
por: Ferar, Kathleen, et al.
Publicado: (2023)

Author Correction: Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
por: Castro-Córdova, Pablo, et al.
Publicado: (2022)

Correction: Product Diversity and Spectrum of Choice in Hospital ePrescribing Systems in England
Publicado: (2014)

Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020)

Correction to: Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin
Publicado: (2023)

Correction to: How did COVID-19 impact on dental antibiotic prescribing across England?
Publicado: (2022)

Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
por: Maaß, Sandra, et al.
Publicado: (2021)

Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection
por: Chaar, Abdelkader, et al.
Publicado: (2021)

Iron Effects on Clostridioides difficile Toxin Production and Antimicrobial Susceptibilities
por: Yamaki, Jason, et al.
Publicado: (2022)

Clostridioides difficile: A diagnostic intervention
por: Alsoubani, Majd, et al.
Publicado: (2022)

Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Clostridioides difficile Infection Among Hospitalized Adults in England
por: Alexandridou, Maria, et al.
Publicado: (2021)

Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales
por: Tydeman, Florence, et al.
Publicado: (2021)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Correction: To prescribe or not to prescribe? A factorial survey to explore veterinarians’ decision making when prescribing antimicrobials to sheep and beef farmers in the UK
Publicado: (2019)

Correction for Paulick et al., “Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank”
por: Paulick, Ashley, et al.
Publicado: (2022)

2397. Effects of antimicrobial surgical prophylaxis on rates of Clostridioides difficile infection
por: Hayes, Sarah K, et al.
Publicado: (2019)

A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile
por: Imwattana, Korakrit, et al.
Publicado: (2021)

Early Life Antimicrobial Exposure: Impact on Clostridioides difficile Colonization in Infants
por: Obiakor, Chinwe Vivien, et al.
Publicado: (2022)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?
por: Patel, Devangi, et al.
Publicado: (2023)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
por: Selle, Kurt, et al.
Publicado: (2020)

Antimicrobial Resistance Patterns in Clostridioides difficile Strains Isolated from Neonates in Germany
por: Tilkorn, Friederike K. M. T., et al.
Publicado: (2020)

Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile
por: Phanchana, Matthew, et al.
Publicado: (2020)

2372. PCR Ribotype and Antimicrobial Susceptibility of Clostridioides (Formerly Clostridium) difficile in Korea
por: Hoo Jeon, Cheon, et al.
Publicado: (2019)

Genotyping and Antimicrobial Susceptibility of Clostridium perfringens and Clostridioides difficile in Camel Minced Meat
por: Fayez, Mahmoud, et al.
Publicado: (2021)

Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection
por: Tortajada-Girbés, Miguel, et al.
Publicado: (2021)

Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
por: Aguilar-Zamora, Emmanuel, et al.
Publicado: (2022)

Melatonin as an Antimicrobial Adjuvant and Anti-Inflammatory for the Management of Recurrent Clostridioides difficile Infection
por: Sutton, S. Scott, et al.
Publicado: (2022)

Characterization of Food Chain Clostridioides difficile Isolates in Terms of Ribotype and Antimicrobial Resistance
por: Marcos, Pilar, et al.
Publicado: (2023)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

Mucosal Vaccination Strategies against Clostridioides difficile Infection
por: Heuler, Joshua, et al.
Publicado: (2023)

2383. Epidemiological and Clinical Features of Clostridioides difficile Infections in Pediatric Oncology and Transplant Patients
por: Barbar, Ruba, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_21jrf60gm5orclufutfhh7ogqr